Type 2 diabetes drug, DPP-4 inhibitor linagliptin, is clinically effective for long-term use, thirty-two country trial suggests
Monday, July 23, 2012 - 10:31
in Health & Medicine
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.